|
Unexpected similarities between raindrops and proteins
May 26, 2004Raindrops and proteins seem to have a lot in common. This has been shown in a new study by scientists at Ume'å University in Sweden. The principle behind the formation of raindrops is very similar to how proteins fold. This knowledge is vital to our understanding of neurodegenerative diseases like ALS.
These findings have been published in the latest issue of the journal Proceedings of the National Academy of Sciences and have caught the attention of the international research community. The study was carried out by the biochemists Mikael Oliveberg and Linda Hedberg at Ume'å University.
To form a raindrop, it is not enough for a few water molecules to stick together. About 100 water molecules have to conglomerate at the same time. If there are fewer, the drop cannot begin to grow, but it falls to pieces immediately.
Using newly developed theory, Linda Hedberg and Mikael Oliveberg have shown that the inscrutable building blocks of the body, proteins, adopt their proper shape in a similar manner. Unlike water, proteins are made up of long chains, and these chains have to instantly fold to a globular form to keep the normal function of the cell. But just like raindrops, it is not enough if just a few segments of the protein chains start tangling together. All parts have to come together at once, otherwise nothing happens. The scientists see a key principle in this.
"Now that we see the similarities between the genesis of raindrops and the folding of proteins we can also analyze protein folding in a clearer light. We have a stringent theory to follow," says Mikael Oliveberg.
The complicated way in which proteins fold offers the advantage that no half-developed proteins are formed. If such half-developed proteins nevertheless accumulate, they tend to stick to each other, which in turn can lead the cell to "commit suicide". Such improper folding in the sensitive nerve cells lies behind severe disorders like ALS, mad-cow disease, and Alzheimer's disease. At present these diseases are incurable because the knowledge of the misfolding process is yet fragmental.
With the aid of the new theory, these scientists are now working to map what parts of the proteins control the folding and what parts are vulnerable to noxious misfolding. The findings could represent an important step toward a more detailed molecular understanding of how proteins behave in our cells and what happens when things go wrong. As so often in the past, parts of the puzzle turn up when they are least expected: in this case the principle behind the formation of raindrops may be the key to understanding neurodegenerative diseases.
"The connection between raindrops and proteins may seem simple, but simple solutions are often the right ones. It also shows how everything fits together in nature. Phenomena recur, but with different faces. If we can understand protein folding with help of this theory, we will also be gaining a greater knowledge of life and why things sometimes go wrong," says Mikael Oliveberg.
Vetenskapsrådet (The Swedish Research Council)
Neurodegenerative Disease News and Current Neurodegenerative Disease Events RSSCan tomatoes carry the cure for Alzheimer's?
The humble tomato could be a suitable carrier for an oral vaccine against Alzheimer's disease, according to HyunSoon Kim from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) in Korea and colleagues from Digital Biotech Inc. and the Department of Biological Science at Wonkwang University. Although their research1, just published online in Springer's journal Biotechnology Letters, is still in the early stages, it is a promising first step towards finding an edible vaccine against the neurodegenerative disease.
Scientists find how neural activity spurs blood flow in the brain
New research from Harvard University neuroscientists has pinpointed exactly how neural activity boosts blood flow to the brain. The finding has important implications for our understanding of common brain imaging techniques such as fMRI, which uses blood flow in the brain as a proxy for neural activity.
Molecular imaging sheds new light on progression of Alzheimer's disease
In the past, physicians were able only to follow the progression of Alzheimer's disease (AD) through careful clinical histories, noting the often subtle changes associated with cognitive decline over a number of years.
RNA Toxicity Contributes to Neurodegenerative Disease, University of Pennsylvania Scientists Say
Expanding on prior research performed at the University of Pennsylvania, Penn biologists have determined that faulty RNA, the blueprint that creates mutated, toxic proteins, contributes to a family of neurodegenerative disorders in humans.
Vaccine triggers immune response, prevents Alzheimer's
A vaccine created by University of Rochester Medical Center scientists prevents the development of Alzheimer's disease-like pathology in mice without causing inflammation or significant side effects.
Researchers find first conclusive evidence of Alzheimer's-like brain tangles in nonhuman primates
Researchers at the Yerkes National Primate Research Center, Emory University, have discovered the first conclusive evidence of Alzheimer's-like neurofibrillary brain tangles in an aged nonhuman primate.
Gene therapy slows progression of fatal neurodegenerative disease in children
Gene therapy to replace the faulty CLN2 gene, which causes a neurodegenerative disease that is fatal by age 8-12 years, was able to slow significantly the rate of neurologic decline in treated children.
Seeing Alzheimer's amyloids
In an important step toward demystifying the role protein clumps play in the development of neurodegenerative disease, researchers have created a stunning three-dimensional picture of an Alzheimer's peptide aggregate using electron microscopy.
Researchers uncover mechanism of action of antibiotic able to reduce neuronal cell death in brain
Virginia Commonwealth University researchers have discovered how an antibiotic works to modulate the activity of a neurotransmitter that regulates brain functions, which eventually could lead to therapies to treat Alzheimer's disease, Huntington's disease, epilepsy, stroke, dementia and malignant gliomas.
Ground-breaking new insight into the development of Alzheimer's disease
According to estimates there are 85,000 Alzheimer patients in our country and approximately 20,000 new cases every year. This spectacular increase is due to the increasing ageing population. Unfortunately it is still unclear precisely which ageing process forms the basis of this spectacular rise in the occurrence of the disease.
More Neurodegenerative Disease News Articles
| © 2008 BrightSurf.com |